SenesTech's Evolve® Approved in New Zealand

SenesTech (Nasdaq: SNES) announced that its fertility control product Evolve received approval for use in New Zealand from the Ministry for Primary Industries and that its exclusive distributor Evicom has received an initial stocking shipment.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Positive)

Rhea-AI Summary

SenesTech (Nasdaq: SNES) announced that its fertility control product Evolve received approval for use in New Zealand from the Ministry for Primary Industries and that its exclusive distributor Evicom has received an initial stocking shipment.

Evolve is positioned as a non‑lethal, environmentally focused rodent control tool aligned with New Zealand's Predator Free 2050 initiative and the country's planned $4.5 billion investment in eradication technology.

Positive

Regulatory approval in New Zealand by the Ministry for Primary Industries
Initial commercial shipment delivered to exclusive distributor Evicom
Evolve aligns with New Zealand's Predator Free 2050 conservation program

Negative

None.

Argus Feb 2 session

+9.73% close to close Open Argus

Details

News Market Reaction – SNES

In the Feb 2 session, SNES gained 9.73%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +9.7% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +9.7% in the session following this news. A strong positive reaction aligns with the clearly expansionary nature of this approval, as Evolve gained access to New Zealand’s Predator Free 2050 program, which expects to spend over $4.5 billion. Historically, SNES has seen modest gains on positive earnings and distribution news but a notable -8.19% drop on the Belize deal, highlighting inconsistency. Investors also faced potential dilution from outstanding warrants under the Aug 15, 2025 S-3 shelf, which could temper the durability of any outsized rally.

Key Figures

Predator Free 2050 spend: over $4.5 billion Predator Free target year: 2050 Q3 2025 revenue: $690,000 +5 more

Predator Free 2050 spend: over $4.5 billion; Expected New Zealand spend on Predator Free 2050 initiative
Predator Free target year: 2050; Target year for New Zealand’s invasive predator eradication program
Q3 2025 revenue: $690,000; Record quarterly revenue reported in Q3 2025
Revenue growth: 43%; Q3 2025 revenue growth vs Q3 2024
Evolve growth: 77% YoY; Q3 2025 growth in Evolve Rodent Birth Control products
Evolve revenue mix: 85%; Share of total revenue from Evolve products in Q3 2025
Q3 2025 gross margin: 62.8%; Gross margin reported for Q3 2025
Cash and investments: $10.2M; Cash and short-term investments as of Sep 30, 2025

Historical Context

5 past events · Latest: Jan 28

5 events

Jan 28
CEO transition

24h Move

-1.0%

Planned retirement of President and CEO Joel Fruendt and leadership transition.
Nov 11
Intl distribution deal

24h Move

-8.2%

Belize Raptor Center added as official Evolve distributor after regulatory approval.
Nov 10
Q3 2025 earnings

24h Move

+2.6%

Record revenue, strong Evolve growth, improved net loss and EBITDA metrics.
Nov 10
E-commerce expansion

24h Move

+2.6%

Evolve Rat Birth Control launched on Lowes.com, expanding consumer reach.
Nov 03
Earnings call notice

24h Move

-0.9%

Announcement of date and webcast details for Q3 2025 earnings release.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

02/02/2026 - 08:00 AM

Supporting New Zealand's Predator Free 2050 Initiative

Initial Stocking Order Fulfilled

PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce that Evolve® has been approved for use in New Zealand by the Ministry for Primary Industries. SenesTech's exclusive distribution partner, Evicom, has been shipped its initial stocking order.

Rodent overpopulation remains a major ecological and economic challenge in New Zealand, threatening native wildlife, agriculture, and urban environments. Evolve is a revolutionary birth control solution that restricts rodent reproduction at its source, offering a non-lethal, environmentally responsible alternative that seamlessly integrates into existing IPM strategies.

New Zealand's Predator Free 2050 initiative is one of the most ambitious conservation programs in the world, aiming to eradicate invasive predators such as rats, stoats, and possums to safeguard native species. New Zealand expects to spend over $4.5 billion on this program, explicitly counting on advancements in technology and the development of more efficient and effective eradication methods to accomplish their goals. Evolve represents an ideal partner for this effort, as it reduces rat populations without the collateral damage of poisons, preserving biodiversity and delicate ecosystems in line with New Zealand's conservation goals.

"We are delivering on our strategy to become the global leader in sustainable fertility control solutions for managing rat populations, while tapping into significant, high-growth markets that are actively seeking sustainable and effective alternatives to traditional rodenticides," said Joel Fruendt, President and CEO of SenesTech. "The Evolve products are aligning with changing regulatory standards and environmental policies. This is especially crucial for New Zealand, where protecting native wildlife is a national priority."

"We have shipped a container to launch the product in New Zealand, and expect to maintain a regular shipping schedule with Evicom," continued Fruendt.

About SenesTech, Inc.

SenesTech is committed to creating healthier environments by sustainably managing animal pest populations through fertility control. The company's groundbreaking products, including Evolve rodent birth control, which integrates seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.

For more information, visit https://senestech.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential scale of product deployment, and the effectiveness of Evolve in New Zealand's Predator Free 2050 initiative. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. These include, but are not limited to, the successful commercialization of our products, regulatory approvals, and market acceptance. SenesTech does not undertake any obligation to update forward-looking statements except as required by law.

Company Contact:
Tom Chesterman, CFO
(928) 233-7533

View original content to download multimedia:https://www.prnewswire.com/news-releases/senestechs-evolve-approved-in-new-zealand-302675862.html

SOURCE SenesTech, Inc.

FAQ

What approval did SenesTech (SNES) receive for Evolve in New Zealand on Feb 2, 2026?

Evolve received regulatory approval for use in New Zealand from the Ministry for Primary Industries. According to SenesTech, the approval allows commercial distribution and use under New Zealand's regulatory framework, enabling the company and partner Evicom to begin shipments and market rollout.

How does SenesTech (SNES) plan to commercialize Evolve in New Zealand after the initial shipment?

SenesTech will sell through its exclusive distributor Evicom, which has received the initial stocking order. According to SenesTech, the company expects to maintain a regular shipping schedule to Evicom to support product availability and ongoing commercial supply.

What role will Evolve play in New Zealand's Predator Free 2050 initiative for SNES?

Evolve is positioned as a non‑lethal tool to reduce rodent reproduction and protect biodiversity. According to SenesTech, Evolve complements integrated pest management and supports Predator Free 2050 goals by reducing reliance on traditional poisons.

What does New Zealand approval for Evolve mean for SenesTech (SNES) investors?

Approval opens a commercial market in a country investing in eradication technologies, potentially supporting revenue growth. According to SenesTech, entry into New Zealand establishes a foothold in a high‑priority conservation market with an initial shipment already completed.

SenesTech's Evolve® Approved in New Zealand